PAR
Click for more information
0.00% 27.5¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION, page-246

  1. Denial
    9,687 Posts.
    lightbulb Created with Sketch. 1234
    clock Created with Sketch.
    21/10/21
    14:55
    Post #: 56972514
    To be fair to shareholder showing some concern with PR...............they're likely to be outcome based individuals.

    What happened to the peer review of 2B data that was due be end of June? This to me will provide more reassurance we're onto a winner than IND opening


    PAR Price at posting: $1.89 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
PMT High-grade lithium zone extended at Patriot's Corvette project, drilling grades at 5%
right-arrow Created with Sketch.
CXO Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
right-arrow Created with Sketch.
HCH Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant
right-arrow Created with Sketch.
NEWS Good debt vs bad debt for the property in your investment portfolio
right-arrow Created with Sketch.
NEWS Hillcrest Energy Unveils Power Factor Correction Prototype to Meet Growing Demand
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
27.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $96.19M
Open High Low Value Volume
27.5¢ 28.5¢ 27.5¢ $50.60K 182.8K

Buyers (Bids)

No. Vol. Price($)
1 1818 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 27600 2
View Market Depth
Last trade - 16.10pm 11/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.